| CSF1R‐and SHP2‐inhibitor‐loaded nanoparticles enhance cytotoxic activity and phagocytosis in tumor‐associated macrophages A Ramesh, S Kumar, D Nandi, A Kulkarni Advanced Materials 31 (51), 1904364, 2019 | 183 | 2019 |
| A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer A Kulkarni, V Chandrasekar, SK Natarajan, A Ramesh, P Pandey, ... Nature biomedical engineering 2 (8), 589-599, 2018 | 181 | 2018 |
| Carbohydrate-Based Label-Free Detection of Escherichia coli ORN 178 Using Electrochemical Impedance Spectroscopy X Guo, A Kulkarni, A Doepke, HB Halsall, S Iyer, WR Heineman Analytical chemistry 84 (1), 241-246, 2012 | 162 | 2012 |
| Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity P Sengupta, S Basu, S Soni, A Pandey, B Roy, MS Oh, KT Chin, ... Proceedings of the National Academy of Sciences 109 (28), 11294-11299, 2012 | 154 | 2012 |
| Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy A Ramesh, A Brouillard, S Kumar, D Nandi, A Kulkarni Biomaterials 227, 119559, 2020 | 89 | 2020 |
| A microfluidic platform for drug screening in a 3D cancer microenvironment HJ Pandya, K Dhingra, D Prabhakar, V Chandrasekar, SK Natarajan, ... Biosensors and Bioelectronics 94, 632-642, 2017 | 88 | 2017 |
| Glycan‐based high‐affinity ligands for toxins and pathogen receptors AA Kulkarni, AA Weiss, SS Iyer Medicinal research reviews 30 (2), 327-393, 2010 | 87 | 2010 |
| A nitric oxide (NO) Nanoreporter for noninvasive real‐time imaging of macrophage immunotherapy A Ramesh, S Kumar, A Brouillard, D Nandi, A Kulkarni Advanced Materials 32 (24), 2000648, 2020 | 81 | 2020 |
| Reporter nanoparticle that monitors its anticancer efficacy in real time A Kulkarni, P Rao, S Natarajan, A Goldman, VS Sabbisetti, Y Khater, ... Proceedings of the National Academy of Sciences 113 (15), E2104-E2113, 2016 | 80 | 2016 |
| Amphiphilic beads as depots for sustained drug release integrated into fibrillar scaffolds AK Gaharwar, SM Mihaila, AA Kulkarni, A Patel, A Di Luca, RL Reis, ... Journal of Controlled Release 187, 66-73, 2014 | 79 | 2014 |
| Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype Y Connor, S Tekleab, S Nandakumar, C Walls, Y Tekleab, A Husain, ... Nature communications 6 (1), 8671, 2015 | 78 | 2015 |
| Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2 AA Kulkarni, C Fuller, H Korman, AA Weiss, SS Iyer Bioconjugate chemistry 21 (8), 1486-1493, 2010 | 74 | 2010 |
| Design principles for clinical efficacy of cancer nanomedicine: a look into the basics S Sengupta, A Kulkarni ACS nano 7 (4), 2878-2882, 2013 | 72 | 2013 |
| Rationally designed 2-in-1 nanoparticles can overcome adaptive resistance in cancer A Goldman, A Kulkarni, M Kohandel, P Pandey, P Rao, SK Natarajan, ... ACS nano 10 (6), 5823-5834, 2016 | 68 | 2016 |
| Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy A Nguyen, A Ramesh, S Kumar, D Nandi, A Brouillard, A Wells, ... Science advances 6 (40), eabc2777, 2020 | 64 | 2020 |
| Comparison of binding platforms yields insights into receptor binding differences between Shiga toxins 1 and 2 MJ Flagler, SS Mahajan, AA Kulkarni, SS Iyer, AA Weiss Biochemistry 49 (8), 1649-1657, 2010 | 52 | 2010 |
| Synthesis of polymeric nanomaterials for biomedical applications AA Kulkarni, PS Rao Nanomaterials in tissue engineering, 27-63, 2013 | 49 | 2013 |
| Combining immune checkpoint inhibitors and kinase-inhibiting supramolecular therapeutics for enhanced anticancer efficacy A Kulkarni, SK Natarajan, V Chandrasekar, PR Pandey, S Sengupta ACS nano 10 (10), 9227-9242, 2016 | 46 | 2016 |
| Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy A Pandey, A Kulkarni, B Roy, A Goldman, S Sarangi, P Sengupta, ... Cancer research 74 (3), 675-685, 2014 | 38 | 2014 |
| Targeting macrophages: a novel avenue for cancer drug discovery S Kumar, A Ramesh, A Kulkarni Expert Opinion on Drug Discovery 15 (5), 561-574, 2020 | 35 | 2020 |
